Centessa Pharmaceuticals shares owned by Cormorant Asset Management
Quarter-by-quarter ownership of Centessa Pharmaceuticals (CNTA) shares owned by Cormorant Asset Management
from 13F filings
Historical chart of Cormorant Asset Management investment in Centessa Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Centessa Pharmaceuticals held by Cormorant Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv

Quarterly reported holdings in Centessa Pharmaceuticals by Cormorant Asset Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-12-31 | $43M | 2.6M | 16.75 |
2024-09-30 | $41M | 2.6M | 15.99 |
2024-06-30 | $15M | 1.6M | 9.03 |
2024-03-31 | $6.3M | 562k | 11.30 |
2023-12-31 | $4.5M | 562k | 7.96 |
2023-09-30 | $3.6M | 562k | 6.47 |
2023-06-30 | $3.5M | 562k | 6.19 |
2023-03-31 | $2.2M | 562k | 3.85 |
2022-12-31 | $1.7M | 562k | 3.10 |
2022-09-30 | $7.9M | 2.0M | 4.02 |
2022-06-30 | $14M | 2.9M | 4.87 |
2022-03-31 | $22M | 2.5M | 8.97 |
2021-12-31 | $28M | 2.5M | 11.26 |
2021-09-30 | $29M | 1.7M | 16.63 |
2021-06-30 | $31M | 1.4M | 21.76 |
More positions owned by Cormorant Asset Management
View all positions for Cormorant Asset Management